Literature DB >> 30093391

Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.

Hsuan-Chen Wang1, Ming-I Hsieh1, Pui-Ching Choi1, Chi-Jung Wu2,3.   

Abstract

This study compared the YeastOne and reference CLSI M38-A2 broth microdilution methods for antifungal susceptibility testing of Aspergillus species. The MICs of antifungal agents were determined for 100 Aspergillus isolates, including 54 Aspergillus fumigatus (24 TR34/L98H isolates), 23 A. flavus, 13 A. terreus, and 10 A. niger isolates. The overall agreement (within 2 2-fold dilutions) between the two methods was 100%, 95%, 92%, and 90% for voriconazole, posaconazole, itraconazole, and amphotericin B, respectively. The voriconazole geometric mean (GM) MICs were nearly identical for all isolates using both methods, whereas the itraconazole and posaconazole GM MICs obtained using the YeastOne method were approximately 1 dilution lower than those obtained using the reference method. In contrast, the amphotericin B GM MIC obtained using the YeastOne method was 3.3-fold higher than that observed using the reference method. For the 24 A. fumigatus TR34/L98H isolates assayed, the categorical agreement (classified according to the CLSI epidemiological cutoff values) was 100%, 87.5%, and 83.3% for itraconazole, voriconazole, and posaconazole, respectively. For four A. niger isolates, the itraconazole MICs were >8 μg/ml using the M38-A2 method due to trailing growth, whereas the corresponding itraconazole MICs obtained using the YeastOne method were all ≤0.25 μg/ml without trailing growth. These data suggest that the YeastOne method can be used as an alternative for azole susceptibility testing of Aspergillus species and for detecting the A. fumigatus TR34/L98H isolates but that this method fails to detect A. niger isolates exhibiting trailing growth with itraconazole. Additionally, for isolates with azole MICs that approach or that are at susceptibility breakpoints or with high amphotericin B MICs detected using the YeastOne method, further MIC confirmation using the reference CLSI method is needed.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus; CLSI M38-A2; Sensititre YeastOne; TR34/L98H; amphotericin B; antifungal susceptibility; azoles; trailing growth

Mesh:

Substances:

Year:  2018        PMID: 30093391      PMCID: PMC6156308          DOI: 10.1128/JCM.00780-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  Clinical evaluation of the Sensititre YeastOne plate for testing susceptibility of filamentous fungi to posaconazole.

Authors:  Reena Patel; Cara Mendrick; Cindy C Knapp; Roger Grist; Paul M McNicholas
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

3.  Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Andrew P Davis; Paul R Rhomberg; Michael A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

4.  Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.

Authors:  D W Denning; S A Radford; K L Oakley; L Hall; E M Johnson; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1997-09       Impact factor: 5.790

5.  Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.

Authors:  Jesús Guinea; Teresa Peláez; Luis Alcalá; Emilio Bouza
Journal:  Diagn Microbiol Infect Dis       Date:  2006-05-02       Impact factor: 2.803

6.  Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Authors:  A J Ullmann; J M Aguado; S Arikan-Akdagli; D W Denning; A H Groll; K Lagrou; C Lass-Flörl; R E Lewis; P Munoz; P E Verweij; A Warris; F Ader; M Akova; M C Arendrup; R A Barnes; C Beigelman-Aubry; S Blot; E Bouza; R J M Brüggemann; D Buchheidt; J Cadranel; E Castagnola; A Chakrabarti; M Cuenca-Estrella; G Dimopoulos; J Fortun; J-P Gangneux; J Garbino; W J Heinz; R Herbrecht; C P Heussel; C C Kibbler; N Klimko; B J Kullberg; C Lange; T Lehrnbecher; J Löffler; O Lortholary; J Maertens; O Marchetti; J F Meis; L Pagano; P Ribaud; M Richardson; E Roilides; M Ruhnke; M Sanguinetti; D C Sheppard; J Sinkó; A Skiada; M J G T Vehreschild; C Viscoli; O A Cornely
Journal:  Clin Microbiol Infect       Date:  2018-03-12       Impact factor: 8.067

7.  Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.

Authors:  Estrella Martín-Mazuelos; Javier Pemán; Anastasio Valverde; Mónica Chaves; M Carmen Serrano; Emilia Cantón
Journal:  J Antimicrob Chemother       Date:  2003-08-13       Impact factor: 5.790

8.  Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.

Authors:  M A Pfaller; D J Diekema; M A Ghannoum; J H Rex; B D Alexander; D Andes; S D Brown; V Chaturvedi; A Espinel-Ingroff; C L Fowler; E M Johnson; C C Knapp; M R Motyl; L Ostrosky-Zeichner; D J Sheehan; T J Walsh
Journal:  J Clin Microbiol       Date:  2009-08-19       Impact factor: 5.948

9.  Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.

Authors:  Jakko van Ingen; Henrich A van der Lee; Ton A J Rijs; Jan Zoll; Tjalling Leenstra; Willem J G Melchers; Paul E Verweij
Journal:  J Antimicrob Chemother       Date:  2014-10-09       Impact factor: 5.790

Review 10.  Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi.

Authors:  Daisuke Hagiwara; Akira Watanabe; Katsuhiko Kamei; Gustavo H Goldman
Journal:  Front Microbiol       Date:  2016-09-21       Impact factor: 5.640

View more
  10 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 2.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

3.  Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 Aspergillus Section Nigri Isolates.

Authors:  B Carrara; R Richards; S Imbert; F Morio; M Sasso; N Zahr; A C Normand; P Le Pape; L Lachaud; S Ranque; D Maubon; R Piarroux; A Fekkar
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

4.  Identification and antifungal susceptibility profiles of Kodamaea ohmeri based on a seven-year multicenter surveillance study.

Authors:  Menglan Zhou; Shuying Yu; Timothy Kudinha; Meng Xiao; He Wang; Yingchun Xu; Hongmei Zhao
Journal:  Infect Drug Resist       Date:  2019-06-12       Impact factor: 4.003

5.  MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of Talaromyces marneffei Isolates from Fujian and Guangxi (China).

Authors:  Lili Fang; Minxue Liu; Chunlan Huang; Jian Guo; Xiaobo Ma; Yanqing Zheng; Wenjuan Wu; Jiangshan Huang; Heping Xu
Journal:  Infect Drug Resist       Date:  2022-07-01       Impact factor: 4.177

6.  Occurrence, Diversity and Anti-Fungal Resistance of Fungi in Sand of an Urban Beach in Slovenia-Environmental Monitoring with Possible Health Risk Implications.

Authors:  Monika Novak Babič; Nina Gunde-Cimerman; Martin Breskvar; Sašo Džeroski; João Brandão
Journal:  J Fungi (Basel)       Date:  2022-08-16

7.  Multicenter Italian Study on "In Vitro Activities" of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip.

Authors:  Giuliana Lo Cascio; Alda Bazaj; Laura Trovato; Silvana Sanna; Stefano Andreoni; Elisabetta Blasi; Marco Conte; Paolo Fazii; Ester Oliva; Valentina Lepera; Gianluigi Lombardi; Claudio Farina
Journal:  Infect Drug Resist       Date:  2022-10-04       Impact factor: 4.177

8.  Azole Resistance and cyp51A Mutation of Aspergillus fumigatus in a Tertiary Referral Hospital in Taiwan.

Authors:  Tsun-Hao Hsu; Po-Yen Huang; Yun-Chen Fan; Pei-Lun Sun
Journal:  J Fungi (Basel)       Date:  2022-08-26

9.  Azole-Resistant Aspergillus fumigatus Clinical Isolate Screening in Azole-Containing Agar Plates (EUCAST E.Def 10.1): Low Impact of Plastic Trays Used and Poor Performance in Cryptic Species.

Authors:  Julia Serrano-Lobo; Ana Gómez; Belén Rodríguez-Sánchez; Patricia Muñoz; Pilar Escribano; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

10.  Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals.

Authors:  Silvio Ragozzino; Daniel Goldenberger; Patrick R Wright; Stefan Zimmerli; Konrad Mühlethaler; Dionysios Neofytos; Arnaud Riat; Katia Boggian; Oliver Nolte; Anna Conen; Hans Fankhauser; Peter W Schreiber; Reinhard Zbinden; Frederic Lamoth; Nina Khanna
Journal:  Open Forum Infect Dis       Date:  2021-12-18       Impact factor: 3.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.